Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
10,000+ US Securities
Unlisted Companies not available on US Stock Exchanges
Professionally managed portfolios, designed by Vested’s research team
Get exposure to 50+ countries via global funds managed by the world’s top fund managers
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together.
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning.
Read about our journey and get to know the leadership team at Vested
Regentis Biomaterials Ltd is an Israel-based regenerative medicine company. The Company is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Its lead product is GellinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage. Its implant combines the precision of photopolymerization with the biocompatibility of PEG and fibrinogen, enabling natural tissue regeneration without the need for cell harvesting or culturing. Regentis Biomaterials Ltd aims to address unmet clinical needs in sports medicine and early-stage osteoarthritis. more
| Time Frame | RGNT | S&P500 | |
|---|---|---|---|
| 1-Week Return | -% | % | 0.45%% |
| 1-Month Return | -% | % | 0.68%% |
| 3-Month Return | -% | % | 4.56%% |
| 6-Month Return | -% | % | 14.34%% |
| 1-Year Return | -% | % | 13.18%% |
| 3-Year Return | -% | % | 72.4%% |
| 5-Year Return | -% | % | 87.84%% |
| 10-Year Return | -% | % | 241.75%% |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| RGNT | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| RGNT | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
REGENTIS BIOMATERIALS LTD/IS (RGNT) share price today is $7.14
Yes, Indians can buy shares of REGENTIS BIOMATERIALS LTD/IS (RGNT) on Vested. To buy REGENTIS BIOMATERIALS LTD/IS from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RGNT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of REGENTIS BIOMATERIALS LTD/IS (RGNT) via the Vested app. You can start investing in REGENTIS BIOMATERIALS LTD/IS (RGNT) with a minimum investment of $1.
You can invest in shares of REGENTIS BIOMATERIALS LTD/IS (RGNT) via Vested in three simple steps:
The price-to-book (P/B) ratio of REGENTIS BIOMATERIALS LTD/IS (RGNT) is 0.00
The market capitalization of REGENTIS BIOMATERIALS LTD/IS (RGNT) is $36.77M
The stock symbol (or ticker) of REGENTIS BIOMATERIALS LTD/IS is RGNT
Link copied